The purpose of the study is to determine the safety and efficacy of 2.5%, 5.0%, and 7.5% AN2690 Solutions compared to the vehicle alone in the treatment of distal, subungual onychomycosis of the great target toenail.
| Condition | Intervention | Phase |
|---|---|---|
| Distal, Subungual Onychomycosis | Drug: AN2690, 2.5% Drug: AN2690, 5% Drug: AN2690, 7.5% Drug: AN2690 Solution Vehicle |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 2.5%, 5.0%, and 7.5% Solutions vs. Vehicle for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail |
Date of article/Start date of trial: 15 May 2008
Trial Phase: Phase 2
clinical Trials Gov ID: NCT00679965
Trial status: Completed